Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jose Flavio Gomes Marin"'
Autor:
Juliano Júlio Cerci, Mateos Bogoni, Valeria Buccheri, Elba Cristina Sá de Camargo Etchebehere, Talita Maira Bueno da Silveira, Otavio Baiocchi, Carlos de Araujo Cunha Pereira Neto, Marcelo Tatit Sapienza, Jose Flavio Gomes Marin, José Cláudio Meneghetti, Yana Novis, Carmino Antonio de Souza, Carlos Chiattone, Marcia Torresan, Celso Dario Ramos
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 40, Iss 3, Pp 245-249 (2018)
Objective: To investigate, in a large prospective multicenter study, whether 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography is sufficiently accurate to identify clinically important bone marrow involvement by Hodgkin's lymphoma to repl
Externí odkaz:
https://doaj.org/article/003fcaa105bc4ee3be43daf9aa7b2117
Autor:
Fernanda Maria Maria Santos, Jose Flavio Gomes Marin, Marcos Santos Lima, Wellington F Silva, Rodrigo D Velasques, Ana Carolina Arrais Maia, Marcelo Junqueira Atanazio, Lucas Bassolli de Oliveira Alves, Frederico Rafael Moreira, Carlos Alberto Buchpiguel, Valeria Buccheri, Vanderson Rocha
Publikováno v:
Blood. 140:6586-6587
Autor:
Jose Flavio, Gomes Marin, Paulo Schiavom, Duarte, Monique Beraldo, Ordones, Heitor Naoki, Sado, Marcelo Tatit, Sapienza, Carlos A, Buchpiguel
Publikováno v:
Journal of nuclear medicine technology.
In this work we assessed the association between the whole skeletal mean standardized uptake value (SUV) measured on
Autor:
Saulo Brito Silva, Carlos Wagner S. Wanderley, José Flavio Gomes Marin, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Fernanda Frozoni Antonacio, Caroline Sales Figueiredo, Mateus Trinconi Cunha, Fernando Q. Cunha, Gilberto de Castro Junior
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: A significant proportion of patients with non-small-cell lung cancer (NSCLC) do not respond to immune checkpoint inhibitors (ICIs). Since metabolic reprogramming with increased glycolysis is a hallmark of cancer and is involved in immune
Externí odkaz:
https://doaj.org/article/21b9dc841f9f476aaeccc1bd673df974
Autor:
Maurício Fernando Silva Almeida Ribeiro, Franciele Hinterholz Knebel, Fabiana Bettoni, Rodrigo Saddi, Karina Perez Sacardo, Felipe Sales Nogueira Amorim Canedo, João Victor Machado Alessi, Andrea Kazumi Shimada, José Flávio Gomes Marin, Anamaria Aranha Camargo, Artur Katz
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract The survival outcomes of the FLAURA trial support osimertinib as the new standard of care for untreated patients harboring activating mutations in the epidermal growth factor receptor (EGFR). Despite the initial response, disease progression
Externí odkaz:
https://doaj.org/article/44561a7f82f943959883dc09c9964b77
Autor:
Felipe de Galiza Barbosa, Marcelo Araujo Queiroz, Rafael Fernandes Nunes, Larissa Bastos Costa, Elaine Caroline Zaniboni, José Flavio Gomes Marin, Giovanni Guido Cerri, Carlos Alberto Buchpiguel
Publikováno v:
Cancer Imaging, Vol 20, Iss 1, Pp 1-23 (2020)
Abstract PSMA PET imaging was originally used to assess biochemical recurrence of prostate cancer (PCa), but its clinical use was promptly extended to detection, staging and therapy response assessment. The expanding use of PSMA PET worldwide has als
Externí odkaz:
https://doaj.org/article/2f1368aa72b54908ba1b5aa0bb985447
Autor:
Felipe de Galiza Barbosa, Marcelo Araújo Queiroz, Rafael Fernandes Nunes, José Flávio Gomes Marin, Carlos Alberto Buchpiguel, Giovanni Guido Cerri
Publikováno v:
Clinics, Vol 73, Iss suppl 1 (2018)
Prostate cancer imaging has become an important diagnostic modality for tumor evaluation. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has been extensively studied, and the results are robust and promising. The advent
Externí odkaz:
https://doaj.org/article/170ea510dfa348f7824720559b4ebdd4